Product Information
TRI-LO-ESTARYLLA TABLET is a generic product labeled by Xiromed LLC, priced at $0.1049 per EA under NDC 70700012085. Its NADAC has been published 411 times since Aug 15, 2018.
Manufacturer
Xiromed LLCNDC
70700012085
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091232On Market Since
1/1/2018
Price Statistics
The NADAC for TRI-LO-ESTARYLLA TABLET has been published 411 times since Aug 15, 2018, and over the history we have for it it has declined 50.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1049 per EA |
|---|---|
| All-time high | $0.2607 (Jun 12, 2019) |
| All-time low | $0.0903 (Nov 20, 2024) |
| 52-week high | $0.1162 |
| 52-week low | $0.1049 |
| Median price | $0.1635 |
| Average price | $0.1633 |
| Largest weekly change | -27.8% (Apr 17, 2024) |
| Weeks tracked | 411 |
| Tracking since | Aug 15, 2018 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRI-LO-ESTARYLLA TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-LO-ESTARYLLA TABLET, manufactured by Xiromed LLC, is $0.1049 per EA (NDC 70700012085), effective Jun 24, 2026.
How has the price of TRI-LO-ESTARYLLA TABLET changed over time?
Over the history we have for it, the NADAC for TRI-LO-ESTARYLLA TABLET has declined 50.0%. It has been tracked across 411 weekly CMS publications since Aug 15, 2018.
What are the highest and lowest recorded NADAC prices for TRI-LO-ESTARYLLA TABLET?
Since Aug 15, 2018, the NADAC for TRI-LO-ESTARYLLA TABLET has ranged from a low of $0.0903 (Nov 20, 2024) to a high of $0.2607 (Jun 12, 2019), with a median of $0.1635 per EA.
Are there cheaper alternatives to TRI-LO-ESTARYLLA TABLET?
8 NADAC-published products share the same active ingredient, strength, and dosage form as TRI-LO-ESTARYLLA TABLET, but none are currently priced below it.
Who manufactures TRI-LO-ESTARYLLA TABLET?
TRI-LO-ESTARYLLA TABLET (NDC 70700012085) is labeled by Xiromed LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification